A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
12/2002
12/31/2002	US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases
12/31/2002	US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators
12/31/2002	US6500438 In ovo vaccination against coccidiosis
12/27/2002	WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002	WO2002102828A2 Chimeric flavivirus vectors
12/27/2002	WO2002102784A2 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors
12/27/2002	WO2002102366A1 Parasiticides for farmed fish
12/27/2002	WO2002102354A1 Lymphatic drug delivery system
12/27/2002	WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002	WO2002102307A2 Nucleoside vaccine adjuvants
12/27/2002	WO2002102155A1 Amenoacetonitrile compounds for controlling endoparasites
12/27/2002	CA2452255A1 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2448971A1 Chimeric flavivirus vectors
12/26/2002	US20020198253 Melatonin derivatives and medicine containing same
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020197332 Treatment for ectoparasites
12/26/2002	US20020197269 Pharmaceutical composition for immunomodulation and preparation of vaccines
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1386507A Compound antiparasitic medicine for fish or full-value feed containing antiparasitic medicine
12/25/2002	CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them
12/24/2002	US6497873 Rhabdovirus comprising heterologous fusion protein which facilitates fusion of rhabdovirus to target cell membrane, heterologous g stem polypeptide, rhabdovirus n, p and l proteins, deletion of nucleotide sequence encoding g protein
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100430A1 Vaccine complex for preventing or treating leishmaniases
12/19/2002	WO2002100418A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193387 As antimalarial agent
12/19/2002	US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002	CA2447891A1 Exothermic formulations for the treatment of ectoparasites
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002	CN1096267C Medicine for treating chicken leucocyte protozoon
12/17/2002	US6495573 Non-systemic control of parasites
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002	US6495146 Administering eimeria spores, oocysts and/or mixtures during incubation of poultry eggs; immunology
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002	WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	WO2002072015A3 M cell directed vaccines
12/12/2002	WO2002002098A3 Antibacterial method and composition with phenolic compounds
12/12/2002	US20020188107 Plant protein for use in the treatment of cancer
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002	US20020187155 Ringworm vaccine
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263785A2 Mutated il-13 molecules and their uses
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263744A1 Nematicidal trifluorobutenes
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263442A1 TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP0820289B1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
12/11/2002	EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002	CN1384832A Pesticidal aminoheterocyclamide compounds
12/11/2002	CN1384826A Pesticidal N-heteroaryl alpha-alkoximino-carboxamides
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1383821A Veterinary injection containing albendazole sulfoxide or its salt
12/11/2002	CN1095660C Pyriquitone releasing agent and its preparation
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492419 Aqueous insecticidal pour-on formulation
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002	US6492342 Hygromycin A prodrugs
12/10/2002	US6491920 Polypeptides and DNA encoding same
12/10/2002	CA2260412C Parasiticidal pyrazoles
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097081A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096892A1 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
12/05/2002	WO2002070557A3 Nuclear hormone receptor ligand binding domain

1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 218